بر اساس عنوان

1
Coronary Artery Bypass Graft Patency and Competitive Flow
2
Coronary artery bypass graft surgery after thrombolytic therapy in the thrombolysis in myocardial infarction trial, Phase II (TIMI II)
3
Coronary artery bypass graft surgery in patients with recent exposure to clopidogrel and aspirin therapy
4
Coronary artery bypass graft surgery outcomes following 6.5 years: A nested case–control study
5
Coronary artery bypass graft surgery patients and their family member caregivers: Outcomes of a family-focused staged psychoeducational intervention
6
Coronary Artery Bypass Grafting (CABG) Without General Anaesthesia- An Initial Experience in NICVD, Dhaka, Bangladesh
7
Coronary artery bypass grafting “On Pump”: role of three-day discharge
8
Coronary Artery Bypass Grafting After a Bilateral Lung Volume Reduction Operation
9
Coronary Artery Bypass Grafting After Previous Stenting is Associated With Compromised Long-Term Efficacy
10
Coronary Artery Bypass Grafting Baseline Cognitive Assessment: Essential Not Optional
11
Coronary Artery Bypass Grafting Combined with Total Occlusion of Internal Carotid Artery
12
Coronary artery bypass grafting in a patient with antiphospholipid syndrome
13
Coronary artery bypass grafting in a patient with total occlusion of both internal carotid arteries
14
Coronary artery bypass grafting in adult coronary artery disease due to suspected Kawasaki disease in childhood
15
Coronary Artery Bypass Grafting in advance aged patients
16
Coronary artery bypass grafting in an immune thrombocytopenic purpura patient using off-pump techniques
17
Coronary artery bypass grafting in dialysis patients
18
Coronary Artery Bypass Grafting In Familial Hypercholesterolemia
19
Coronary Artery Bypass Grafting in Immune Thrombocytopenic Purpura
20
Coronary artery bypass grafting in patients after failure of intracoronary stenting
21
Coronary artery bypass grafting in patients on chronic hemodialysis: surgical outcome in diabetic nephropathy versus nondiabetic nephropathy patients
22
Coronary artery bypass grafting in patients who require long-term dialysis
23
Coronary artery bypass grafting in patients with advanced left ventricular dysfunction
24
Coronary Artery Bypass Grafting in Patients with Advanced Left Ventricular Dysfunction: Excellent Early Outcome with Improved Ejection Fraction
25
Coronary artery bypass grafting in patients with cerebrovascular disease Review Article
26
Coronary artery bypass grafting in the elderly
27
Coronary artery bypass grafting in type II diabetic patients: a comparison between insulin-dependent and non-insulin-dependent patients at short- and mid-term follow-up
28
Coronary Artery Bypass Grafting is Associated With Excellent Long-Term Survival and Quality of Life: A Prospective Cohort Study
29
Coronary Artery Bypass Grafting is Still the Best Treatment for Multivessel and Left Main Disease, But Patients Need to Know
30
Coronary Artery Bypass Grafting is Superior to Percutaneous Coronary Intervention in Prevention of Perioperative Myocardial Infarctions During Subsequent Vascular Surgery
31
Coronary artery bypass grafting on the beating heart: a simple technique for subluxating the heart
32
Coronary Artery Bypass Grafting Using an Abdominal Artery as an Inflow
33
Coronary artery bypass grafting using the gastroepiploic artery in 1,000 patients
34
Coronary artery bypass grafting using the radial artery: midterm results in a Japanese institute
35
Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy
36
Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Left Main Coronary Artery Disease (from a Two-Center Registry)
37
Coronary artery bypass grafting with an expanded polytetrafluoroethylene graft
38
Coronary artery bypass grafting with cardiopulmonary bypass versus off-pump cardiopulmonary bypass grafting: does eliminating the pump reduce morbidity and cost?
39
Coronary artery bypass grafting with gastroepiploic artery composite graft
40
Coronary artery bypass grafting with left internal mammary artery and right gastroepiploic artery, with and without bypass  
41
Coronary Artery Bypass Grafting With Single Cross-Clamp Results in Fewer Persistent Neuropsychological Deficits Than Multiple Clamp or Off-Pump Coronary Artery Bypass Grafting
42
Coronary artery bypass grafting within 30 days of an acute myocardial infarction
43
Coronary artery bypass grafting without cardiopulmonary bypass
44
Coronary artery bypass grafting without cardiopulmonary bypass
45
Coronary artery bypass grafting without cardiopulmonary bypass and without interruption of native coronary flow using novel anastomosis site restraining device (“Octopus”)
46
Coronary artery bypass grafting without cardiopulmonary bypass through sternotomy and minimally invasive procedure
47
Coronary Artery Bypass Grafting: A Precipitating Factor for Perioperative Diabetic Ketoacidosis
48
Coronary Artery Bypass Grafting: Long-Term Psychological and Social Outcomes
49
Coronary artery bypass in patients 80 years and over: is off-pump the operation of choice?
50
Coronary Artery Bypass is Superior to Drug-Eluting Stents in Multivessel Coronary Artery Disease
51
Coronary artery bypass operation after pneumonectomy
52
Coronary Artery Bypass Risk Prediction Using Neural Networks
53
Coronary Artery Bypass Surgery and Acute Kidney Injury: Impact of the Off-Pump Technique
54
Coronary artery bypass surgery by the transdiaphragmatic approach
55
Coronary Artery Bypass Surgery in Coronary Artery Disease Concomitant with Porcelain Aorta: Great Challenge for Cardiac surgeon
56
Coronary artery bypass surgery in octogenarians: outcomes in a tertiary referral university hospital in a developing country
57
Coronary artery bypass surgery in patients with severe left ventricular dysfunction
58
Coronary artery bypass surgery is still cost-effective: using calibrated models toupdate clinical trials
59
Coronary artery bypass surgery or percutaneous coronary intervention after fibrinolysis: A critical reappraisal
60
Coronary Artery Bypass Surgery versus Medical Treatment in Patients with Low Ejection Fraction and Coronary Artery Disease
61
Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial
62
Coronary artery bypass surgery: Why donʹt the wealthy choose the best hospitals?
63
Coronary artery bypass via diaphragmatic approach with free graft
64
Coronary artery bypass: a userʹs manual
65
Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach
66
Coronary Artery Calcification and Changes in Atheroma Burden in Response to Established Medical Therapies Original Research Article
67
Coronary Artery Calcification and Myocardial Perfusion in Asymptomatic Adults: The MESA (Multi-Ethnic Study of Atherosclerosis) Original Research Article
68
Coronary Artery Calcification and Myocardial Perfusion: Kissing Cousins or Distant Relatives?
69
Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism
70
Coronary artery calcification in black women and white women
71
Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study
72
Coronary artery calcification on computed tomography
73
Coronary artery calcification on computed tomography
74
Coronary artery calcification on computed tomography
75
Coronary artery calcification on computed tomography
76
Coronary artery calcification screening to rule out acute myocardial infarction prior to hospital admission
77
Coronary Artery Calcification, an Improvement in Risk Classification: Need for Reappraisal?
78
Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors
79
Coronary artery calcification: “...empty your cup...”, ,
80
Coronary Artery Calcification: Pathogenesis and Prognostic Implications
81
Coronary artery calcifications in the long-term follow-up of Kawasaki disease
82
Coronary artery calcium (CAC) score – a prognostic tool in coronary artery disease
83
Coronary Artery Calcium and Risk of Atrial Fibrillation (from the Multi-Ethnic Study of Atherosclerosis)
84
Coronary artery calcium as a measure of biologic age
85
Coronary Artery Calcium Detected by Digital Fluoroscopy and Risk Factors in Healthy Subjects
86
Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events
87
Coronary Artery Calcium Progression: An Important Clinical Measurement?: A Review of Published Reports
88
Coronary artery calcium scanning: Clinical paradigms for cardiac risk assessment and treatment
89
Coronary Artery Calcium Score Assessment in Breast Cancer Patients After Three-Dimensional Conformal Radiotherapy: Is Calcium Score an Appropriate Screening Study?
90
Coronary artery calcium score, risk factors, and incident coronary heart disease events
91
Coronary Artery Calcium Score: A Review
92
Coronary Artery Calcium to Predict All-Cause Mortality in Elderly Men and Women Original Research Article
93
Coronary Artery Calcium Versus Intima-Media Thickness as a Measure of Cardiovascular Disease Among Asymptomatic Adults (from The Rancho Bernardo Study)
94
Coronary artery calcium volume scores on electron beam tomography in 12,936 asymptomatic adults
95
Coronary Artery Calcium, Carotid Artery Wall Thickness, and Cardiovascular Disease Outcomes in Adults 70 to 99 Years Old
96
Coronary artery calcium, exercise tolerance, and CHD events in asymptomatic men
97
Coronary Artery Complications in Infective Endocarditis
98
Coronary Artery Diameter as a Risk Factor for Acute Coronary Syndromes in Asian-Indians
99
Coronary Artery Diameters in Infants and Children With Congenital Heart Disease as Determined by Computed Tomography
100
Coronary artery dimensions in primary and secondary left ventricular hypertrophy
101
Coronary artery disease after heart transplantation and its relation to cytomegalovirus
102
Coronary Artery Disease and High Altitude: Unresolved Issues
103
Coronary Artery Disease and Its Risk Factors Status in Iran: A Review
104
Coronary artery disease and opioid use
105
Coronary artery disease and plasma apolipoprotein E4 in mild cognitive impairment
106
Coronary Artery Disease in critical patients of Iran
107
Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease: A report from the Coronary Artery Surgery Study Registry, ,
108
Coronary artery disease in diabetic patients: A major therapeutic challenge
109
Coronary artery disease in identical twins
110
Coronary artery disease in identical twins
111
Coronary artery disease in India: challenges and opportunities
112
Coronary artery disease in Iranian overweight women
113
Coronary Artery Disease in Minority Racial and Ethnic Groups in the United States
114
Coronary artery disease in patients at low risk — apolipoprotein AI as an independent risk factor
115
Coronary artery disease in patients undergoing valve replacement at a tertiary care cardiac centre
116
Coronary Artery Disease in patients with chest pain who have low-risk clinical characteristics and negative cardiac troponin I
117
Coronary artery disease in patients with chronic kidney disease: a brief literature review
118
Coronary artery disease in patients with heart failure and preserved systolic function
119
Coronary artery disease in patients with peripheral artery disease
120
Coronary Artery Disease in Patients With Psoriasis Referred for Coronary Angiography
121
Coronary artery disease in patients with type A aortic dissection
122
Coronary artery disease in the developing world
123
Coronary artery disease in the LDL-Apheresis atherosclerosis regression study (LAARS)
124
Coronary artery disease in young adults
125
Coronary Artery Disease in Young: Faulty Life Style or Heredofamilial or Both
126
Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects
127
Coronary artery disease is more than just coronary lumen disease
128
Coronary Artery Disease Presentation and Its Association with Shortened Activated Partial Thromboplastin Time
129
Coronary Artery Disease Prognosis and C-Reactive Protein Levels Improve in Proportion to Percent Lowering of Low-Density Lipoprotein
130
Coronary artery disease progression assessed by electron-beam computed tomography
131
Coronary Artery Disease Progression Late After Successful Stent Implantation
132
Coronary Artery Disease Risk Factors in an Urban and Peri-urban Setting, Kerman, Southeastern Iran (KERCADR Study): Methodology and Preliminary Report
133
CORONARY ARTERY DISEASE RISK FACTORS IN DRIVERS VERSUS PEOPLE IN OTHER OCCUPATIONS
134
Coronary Artery Disease Risk Factors in Patients Undergoing Coronary Artery Bypass Graft Surgery
135
Coronary Artery Disease: A Review of Risk Factors
136
Coronary artery disease: changes of blood lymphocyte subsets induced by physical exercise
137
Coronary artery disease: the folate link
138
Coronary artery disease: the Scandinavian Simvastatin Survival Study Experience
139
Coronary Artery Diseases in Women
140
Coronary artery dissection
141
Coronary artery dissection after blunt chest trauma: Depiction at multidetector-row computed tomography
142
Coronary artery dissection following angioplasty detected by multi-detector row computed tomography: Evaluation using the Plaque Map system
143
Coronary Artery Dissection in a Woman With Previous Systemic Lupus Erythematosus Using Oral Contraceptive Pills
144
Coronary Artery Distensibility Assessed by 3.0 Tesla Coronary Magnetic Resonance Imaging in Subjects With and Without Coronary Artery Disease
145
Coronary artery distensibility in diabetic patients with simultaneous measurements of luminal are and intracoronary pressure : Evidence of impaired reactivity to nitroglycerin
146
Coronary Artery Dominance: What pattern exists in Pakistani Population?
147
Coronary Artery Ectasia in a Patient with Polycystic Kidney Disease
148
Coronary artery ectasia is associated with atrial electrical and mechanical dysfunction: an observational study
149
Coronary Artery Ectasia is Associated with the Elevation of Mean Platelet Volume Regardless of an Existing Acute Coronary Syndrome
150
Coronary Artery Ectasia Presenting as a Non-ST Elevation Myocardial Infarction in a Young Adult: Case Presentation and Literature Review
151
Coronary Artery Ectasia, its Clinical Profile and Angiographic Characteristics, Single Centre Experience
152
Coronary artery ectasia: Is it a destructive inflammatory lesion of the vascular wall?
153
Coronary artery endarterectomy for retrieval of entrapped percutaneous angioplasty catheter
154
Coronary artery endothelial function after myocardial ischemia and reperfusion
155
Coronary artery endothelial protection after local delivery of 17β-estradiol during balloon angioplasty in a porcine model: a potential new pharmacologic approach to improve endothelial function
156
Coronary Artery Erosion and Dissection: An Unusual Complication of Mitral Annular Calcification
157
Coronary Artery Fistula
158
Coronary Artery Fistula and Pectus Excavatum Paradox
159
Coronary Artery Fistula as a Bypass of a Left Anterior Descending Coronary Artery Stenosis
160
Coronary Artery Fistula Diagnosed by Echocardiography during NSTEMI: Case Report and Review of Literature
161
Coronary artery fistula draining into the pulmonary artery
162
Coronary Artery Fistula from Left Circumflex to Coronary
163
Coronary artery fistula in children and adults: a review of 25 cases with long-term observations
164
Coronary artery fistula presented as infective endocarditis with pulmonary septic emboli
165
Coronary Artery Fistula with Double Outlet Right Ventricle: a Case Report
166
Coronary Artery Fistula with Double Outlet Right Ventricle: a Case Report
167
Coronary artery fistula: multidetector row computed tomography angiography in young child
168
Coronary artery fistulae from single coronary artery in a patient with rheumatic mitral stenosis
169
Coronary artery fistulas in infants and children: A surgical review and discussion of coil embolization
170
Coronary artery fistulas presenting with bacterial endocarditis
171
Coronary artery fistulas: Clinical and therapeutic considerations
172
Coronary artery fistulas: long-term results of surgical correction
173
Coronary artery flow measurement using navigator echo gated phase contrast magnetic resonance velocity mapping at 3.0 T
174
Coronary artery flow measurement with magnetic resonance imaging: validation with ultrasound
175
Coronary artery flow ten weeks after myocardial infarction or unstable angina: effects of combined warfarin and aspirin therapy
176
Coronary Artery Hematoma Treated with Fenestration Using a Novel NSE AlphaD Scoring Balloon
177
Coronary artery imaging with multidetector computed tomography: A call for an evidence-based, multidisciplinary approach
178
Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization
179
Coronary artery intimal hyperplasia, occlusive platelet thrombus, and fatal myocardial infarction in an intravenous cocaine user
180
Coronary artery involvement early and late after radiofrequency current application in young pigs, , ,
181
Coronary Artery Involvement Kawasaki Disease Versus Non-Kawasaki Febrile Diseases in Children Attending a Pediatric Hospital in Bandar Abbas
182
Coronary Artery Manifestations of Fibromuscular Dysplasia
183
Coronary artery morphologic features after coronary rotational atherectomy: Insights into mechanisms of lumen enlargement and embolization
184
Coronary artery narrowing after aortic root reconstruction with resorcin-formalin glue
185
Coronary Artery Obstruction After the Arterial Switch Operation for Transposition of the Great Arteries in Newborns
186
Coronary artery obstruction caused by perivalvular abscess in aortic valve endocarditis
187
Coronary artery obstruction due to membranous ridge of the right sinus valsalva associated with Tetralogy of Fallot: syncope mimics anoxic spell
188
Coronary artery operation in patients after breast cancer therapy
189
Coronary Artery Origin Anomalies with Especial Emphasis on Delayed Diagnosis of Anomalous Origin of the Left Coronary Artery from Pulmonary Artery, A report from South of Iran
190
Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in the hurler syndrome
191
Coronary Artery Perforation after Guidewire Removal
192
Coronary artery problems during homograft aortic valve replacement: role of transesophageal echocardiography
193
Coronary artery reconstruction for extensive coronary disease: 108 patients and two year follow-up
194
Coronary Artery Reconstruction: Optimal Technique of Coronary Endarterectomy
195
Coronary artery reoperation through the left thoracotomy with hypothermic circulatory arrest
196
Coronary artery response to cold-pressor test is impaired early after operation in heart transplant recipients
197
Coronary artery restenosis after atherectomy is primarily due to negative remodeling
198
Coronary Artery Revascularization (CARE) Registry: An Observational Study of On-Pump and Off-Pump Coronary Artery Revascularization
199
Coronary Artery Revascularization After Chest Wall Reconstruction With Rectus Abdominis Myocutaneous Flap
200
Coronary Artery Revascularization in a young adult with Solitary Coronary Aneurysm probably secondary to childhood Kawasaki Disease
201
Coronary Artery Revascularization in a Young Adult with Solitary Coronary Aneurysm ProbablySecondary to Childhood Kawasaki Disease
202
Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction
203
Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome
204
Coronary artery spasm and ventricular fibrillation after off-pump coronary surgery Coronary artery spasm and ventricular fibrillation after off-pump coronary surgery
205
Coronary Artery Spasm as a Frequent Cause of Acute Coronary Syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study Original Research Article
206
Coronary Artery Spasm During Dobutamine Stress Echocardiography: A Case Report
207
Coronary Artery Spasm: A Rare But Important Cause of Postoperative Myocardial Infarction
208
Coronary Artery Spatial Distribution, Morphology, and Composition of Nonculprit Coronary Plaques by 64-Slice Computed Tomographic Angiography in Patients With Acute Myocardial Infarction
209
Coronary artery stenoses: A phantom study using contrast enhanced three-dimensional electron beam tomography
210
Coronary artery stenosis morphology and degree of vasomotion in patients with Prinzmetalʹs variant angin
211
Coronary artery stent mimicking intracardiac thrombus on cardiac magnetic resonance imaging due to signal loss: case report
212
Coronary artery stent outcomes in a Medicare population: Less emergency bypass surgery and lower mortality rates in patients with stents, , ,
213
Coronary artery stent placement as a treatment of acute coronary syndrome in course of variant angina
214
Coronary artery stent placement in patients with variant angina refractory to medical treatment
215
Coronary artery stent restenosis responds favorably to repeat interventions
216
Coronary artery stenting in a patient with angina pectoris caused by coronary artery dissection after blunt chest trauma
217
Coronary artery stenting in cardiac allograft vascular disease
218
Coronary artery stenting in the aged
219
Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up
220
Coronary artery stents
221
Coronary Artery Surgery
222
Coronary artery surgery is associated with different forms of atherogenic lipoprotein modifications
223
Coronary artery to the left atrial fistula after resection of atrial appendages
224
Coronary artery-left ventricular micro-fistulas associated with apical hypertrophic cardiomyopathy
225
Coronary artery-to-left ventricular fistula
226
Coronary atherectomy and thrombectomy
227
Coronary Atheroma Regression and Plaque Characteristics Assessed by Grayscale and Radiofrequency Intravascular Ultrasound After Aerobic Exercise
228
Coronary atherosclerosis and body iron stores
229
Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols
230
Coronary Atherosclerosis and Quantitative Myocardial Perfusion: A Relationship Beyond Stenosis
231
Coronary atherosclerosis in diabetes mellitus: A population-based autopsy study
232
Coronary atherosclerosis in unheralded sudden coronary death under age 50: histo-pathologic comparison with ‘healthy’ subjects dying out of hospital
233
Coronary Atherosclerosis Is Associated With Macrophage Polarization in Epicardial Adipose Tissue
234
Coronary atherosclerosis stabilization: an achievable goal Original Research Article
235
Coronary Atherosclerosis: Adiponectin and Leptin as Predictors of Disease Severity
236
Coronary atherosclerosis: is the process focal or diffuse among patients with symptomatic or fatal myocardial ischemia?
237
Coronary atherosclerotic lesions in human immunodeficiency virus–infected patients: a histopathologic study
238
Coronary Bifurcation Lesions Treated With Simple Approach (from the Cordoba & Las Palmas [CORPAL] Kiss Trial)
239
Coronary blood flow during reperfusion as an index of the extend of microvascular damage: Experimental study
240
Coronary blood flow dynamics during transcutaneous electrical nerve stimulation for stable angina pectoris associated with severe narrowing of one major coronary artery
241
Coronary Blood Flow in Patients With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Implantation
242
Coronary blood flow reserve in acute aortic regurgitation
243
Coronary blood flow velocity during apical versus septal pacing
244
Coronary blood flow velocity in normal infants and young adults assessed by transthoracic echocardiography
245
Coronary bypass and carotid endarterectomy: does a combined approach increase risk? A metaanalysis
246
Coronary bypass flow during use of intraaortic balloon pumping and left ventricular assist device
247
Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years
248
Coronary bypass grafting via minithoracotomy on the beating heart
249
Coronary Bypass Grafting Without Use of Cardiopulmonary Bypass for Dextrocardia
250
Coronary Bypass in Women
251
Coronary bypass surgery in women: a long-term comparative study of quality of life after bilateral internal mammary artery grafting in men and women
252
Coronary Calcification and Coronary Artery Disease
253
Coronary calcification and coronary atherosclerosis in asymptomatic persons
254
Coronary Calcification and Coronary Atherosclerosis: Site by Site Comparative Morphologic Study of Electron Beam Computed Tomography and Coronary Angiography
255
Coronary calcification by electron beam computed tomography and obstructive coronary artery disease: model for costs and effectiveness of diagnosis as compared with conventional cardiac testing methods
256
Coronary calcification could predict risk of stroke
257
Coronary calcification is more predictive of carotid intimal medial thickness in black compared to white middle aged men
258
Coronary calcification mimicking the stent: Analysis by MDCT Plaque Map
259
Coronary calcification score and predicted risk of coronary heart disease
260
Coronary calcification score: the coronary-risk impact factor
261
Coronary Calcification, Coronary Disease Risk Factors, C-Reactive Protein, and Atherosclerotic Cardiovascular Disease Events: The St. Francis Heart Study Original Research Article
262
Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain
263
Coronary calcium and cardiovascular event risk: Evaluation by age- and sex-specific quartiles
264
Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography, ,
265
Coronary calcium as a reliable tool for differentiating ischemic from nonischemic cardiomyopathy
266
Coronary calcium as a risk factor: role in global risk assessment
267
Coronary calcium detected by digital cinefluoroscopy and coronary artery disease in patients undergoing coronary arteriography: effects of age and sex
268
Coronary Calcium Independently Predicts Incident Premature Coronary Heart Disease Over Measured Cardiovascular Risk Factors: Mean Three-Year Outcomes in the Prospective Army Coronary Calcium (PACC) Project Original Research Article
269
Coronary Calcium Predicts Events Better With Absolute Calcium Scores Than Age-Sex-Race/Ethnicity Percentiles: MESA (Multi-Ethnic Study of Atherosclerosis)
270
Coronary Calcium Predicts Myocardial Infarction in Asymptomatic Subjects After Two Years of Follow-up
271
Coronary calcium progression rates with a zero initial score by electron beam tomography
272
Coronary Calcium Remains an Effective Filter for Invasive Angiography
273
Coronary calcium scanning adds incremental value to patients with positive stress tests
274
Coronary Calcium Score Improves Classification of Coronary Heart Disease Risk in the Elderly: The Rotterdam Study
275
Coronary Calcium Scoring: Calcium Location Needs to Be Integrated!
276
Coronary calcium: Is racial profiling necessary?
277
Coronary calcium: The good, the bad, and the uncertain, ,
278
Coronary Circulation Responses to Binodenoson, a Selective Adenosine A2A Receptor Agonist
279
Coronary Collateral Circulation: Effect on Early and Midterm Outcomes After Off-Pump Coronary Artery Bypass Surgery
280
Coronary collateral circulation: The effects of smoking and alcohol
281
Coronary collateral development during chronic ischemia: serial assessment using harmonic myocardial contrast echocardiography
282
Coronary Collateral Function Long After Drug-Eluting Stent Implantation Original Research Article
283
Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements
284
Coronary collaterals in patients with normal and impaired left ventricular systolic function
285
Coronary collaterals, stenoses, and stents: Is a new era of physiologic-guided percutaneous revascularization emerging?
286
Coronary collaterals: The role of MCP-1 during the early phase of acute myocardial infarction
287
Coronary collaterals—insights in molecular determinants and prognostic relevance
288
Coronary Collaterals—Too Small to Be Eyeballed, Too Large to Be Meaningless
289
Coronary Complications of Kawasaki Disease: Novel Diagnosis Based on Z-score and Absolute Dimension
290
Coronary Computed Tomographic Angiographic Findings in Asymptomatic Patients With Heterozygous Familial Hypercholesterolemia and Null Allele Low-Density Lipoprotein Receptor Mutations
291
Coronary Computed Tomographic Angiographic Findings in Asymptomatic Patients With Type 2 Diabetes Mellitus
292
Coronary Computed Tomographic Angiographic Findings in Patients With Kawasaki Disease
293
Coronary Computed Tomographic Angiography as a Gatekeeper to Invasive Diagnostic and Surgical Procedures: Results From the Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) Registry
294
Coronary Computed Tomographic Angiography for Prediction of Procedural and Intermediate Outcome of Bypass Grafting to Left Anterior Descending Artery Occlusion With Failed Visualization on Conventional Angiography
295
Coronary Computed Tomography Angiography After Stress Testing
296
Coronary Computed Tomography Angiography After Stress Testing: Results From a Multicenter, Statewide Registry, ACIC (Advanced Cardiovascular Imaging Consortium)
297
Coronary Computed Tomography Angiography as a Screening Tool for the Detection of Occult Coronary Artery Disease in Asymptomatic Individuals Original Research Article
298
Coronary Computed Tomography Angiography for Early Triage of Patients With Acute Chest Pain: The ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) Trial
299
Coronary computed tomography angiography in a patient with atrial fibrillation, case report
300
Coronary Computed Tomography Angiography in the Emergency Department: The High Stakes Game of Low Risk Chest Pain
301
Coronary Computed Tomography Angiography Versus Coronary Calcium Computed Tomography for Prognosis With Regard to Mortality
302
Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-Analysis of Prospective Trials
303
Coronary Computed Tomography Angiography: CONFIRMations and Perspectives
304
Coronary Computed Tomography Angiography: Is it Time to Replace the Conventional Coronary Angiogram in Heart Transplant Patients?
305
Coronary Computed Tomography Angiography: Our Time Has Come, But There Are Miles to Go Before We Sleep
306
Coronary Computed Tomography Angiography: The Challenge of Coronary Calcium
307
Coronary Connector Devices: Analysis of 1,469 Anastomoses in 1,216 Patients
308
Coronary constriction in constrictive pericarditis
309
Coronary C-reactive protein distribution: its relation to development of atherosclerosis
310
Coronary CT Angiography Again Results in Better Patient Outcomes
311
Coronary CT Angiography and Dual-Energy Computed Tomography in Ischemic Heart Disease Suspected Patients
312
Coronary cyclic flow variations following primary angioplasty is associated with poor short-term prognosis
313
Coronary Diameter and Vasodilator Function in Children Following Arterial Switch Operation for Complete Transposition of the Great Arteries
314
Coronary Dilator Reserve and Morphological Changes After Relief of Pressure-overload in Rats
315
Coronary disease––prone behavior among Japanese men: Job-centered lifestyle and social dominance, ,
316
Coronary dissection and thrombosis after ingestion of ephedra
317
Coronary dominance and prognosis of patients with acute coronary syndrome
318
Coronary Doppler intensity changes during handgrip: new method to detect coronary vasomotor tone in coronary artery disease
319
Coronary drug-eluting stent development: Issues in trial design
320
Coronary echocardiography in tetralogy of Fallot: diagnostic accuracy, resource utilization and surgical implications over 13 years
321
Coronary Ectasia Is Associated with Impaired Left Ventricular Myocardial Performance in Patients without Significant Coronary Artery Stenosis
322
Coronary Emboli in a Young Patient with Mechanical Aortic Valve: A Rare Cause of Acute Myocardial Infarction
323
Coronary Embolism and Myocardial Infarction in a Transgender Male Undergoing Hormone Therapy: A Case Report and Review of the Literature
324
Coronary Embolism and Subsequent Myocardial Abscess Complicating Ventricular Aneurysm and Tachycardia
325
Coronary embolism causing myocardial infarction in a patient with mechanical aortic valve prosthesis
326
Coronary embolism complicating an atrial myxoma
327
Coronary embolism complicating aortic valve endocarditis: Treatment with successful coronary angioplasty
328
Coronary Embolization in Bullet Wounds: Role of Perioperative Coronary Angiography
329
Coronary embolization of a proximal vessel due to retrieval of a balloon catheter with an organized thrombus during primary PCI
330
Coronary embolus secondary to a prosthetic mitral valve and subtherapeutic anticoagulation
331
Coronary endarterectomy and stent removal after iatrogenic perforation
332
Coronary Endarterectomy and Stent Removal in Patients With In-Stent restenosis
333
Coronary endarterectomy with off-pump coronary artery bypass surgery
334
Coronary Endarterectomy: Impact on Morbidity and Mortality When Combined With Coronary Artery Bypass Surgery
335
Coronary Endarterectomy: The Choice of Tactics is Dictated by the Lay of the Land
336
Coronary endothelial dysfunction after Kawasaki disease
337
Coronary Endothelial Dysfunction After Kawasaki Disease: Evaluation by Intracoronary Injection of Acetylcholine
338
Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans
339
Coronary endothelial dysfunction and inflammation of coronary atherosclerosis
340
Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy
341
Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy
342
Coronary endothelial dysfunction in the early months after heart transplantation
343
Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress
344
Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid
345
Coronary Endothelial Dysfunction Precedes Heart Failure and Reduction of Coronary Reserve in Awake Dogs
346
Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease
347
Coronary endothelial injury after local occlusion on the human beating heart
348
Coronary Endothelial Vasomotor Function and Vascular Remodeling in Heart Transplant Recipients Randomized for Tacrolimus or Cyclosporine Immunosuppression Original Research Article
349
Coronary endothelium expresses a pathologic gene pattern compared to aortic endothelium: Correlation of asynchronous hemodynamics and pathology in vivo
350
Coronary end-to-side sleeve anastomosis using adhesive in off-pump bypass grafting in the pig
351
Coronary events and coronary care: MONICA project
352
Coronary events and coronary care: MONICA project
353
Coronary events and coronary care: MONICA project
354
Coronary events and coronary care: MONICA project
355
Coronary fistula between the left anterior descending coronary artery and the pulmonary artery: Two case reports
356
Coronary Flow Assessment in Unstable Angina/non ST-segment Elevation Myocardial Infarction Patients via Thrombolysis in Myocardial Infarction Frame Count in Angiography
357
Coronary Flow Dynamics Measured by Computed Tomography Angiography
358
Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries
359
Coronary flow reserve and brachial artery reactivity in patients with chest pain and “false positive” exercise-induced ST-segment depression
360
Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension
361
Coronary Flow Reserve Assessed by Transesophageal Echocardiography Identifies Early Restenosis of the Left Anterior Descending Coronary Artery Angioplasty
362
Coronary flow reserve assessment by dobutamine transesophageal doppler echocardiography
363
Coronary flow reserve assessment by dobutamine transesophageal doppler echocardiography
364
Coronary flow reserve assessment from average peak velocity profiles alone must be judged with caution
365
Coronary Flow Reserve Before and After Coronary Artery Bypass Surgery
366
Coronary flow reserve does not adequately interrogate coronary microvascualr function  
367
Coronary Flow Reserve During Coronary Angioplasty in Patients With Recent Myocardial Infarction: Relation to Stenosis and Myocardial Viability
368
Coronary flow reserve impairment predicts cardiac events in heart transplant patients with preserved left ventricular function
369
Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study
370
Coronary flow reserve in composite arterial Y grafts
371
Coronary Flow Reserve in Hypertensive Patients With Hypercholesterolemia and Without Coronary Heart Disease
372
Coronary Flow Reserve in the Left Anterior Descending Artery Patients, Diagnostic and Prognostic Value of Doppler Echocardiogrphy
373
Coronary flow reserve is also impaired in patients with subclinical hypothyroidism
374
Coronary flow reserve is impaired in patients with aortic valve calcification
375
Coronary flow reserve is impaired in patients with slow coronary flow
376
Coronary Flow Reserve Is Impaired in Young Men With Familial Hypercholesterolemi
377
Coronary flow reserve may predict myocardial recovery after myocardial infarction in patients with TIMI grade 3 flow, ,
378
Coronary flow reserve measurement in the coronary sinus in pre and post CABG status
379
Coronary flow reserve of the angiographically normal left anterior descending coronary artery in patients with remote coronary artery disease
380
Coronary flow reserve or brachial artery flow to assess endothelial dysfunction: is it time to look at the heart again?
381
Coronary Flow Reserve With a Turbo: A Warning for the Use of Adenosine as a Provocative Test in Patients Receiving Ticagrelor?
382
Coronary flow studies for risk stratification in multivessel disease: A physiologic bridge too far?
383
Coronary flow velocity changes after intravenous dipyridamole infusion: Measurements using intravascular Doppler guide wire documentation of flow inhomogeneity
384
Coronary flow velocity immediately after primary coronary stenting as a predictor of ventricular wall motion recovery in acute myocardial infarction
385
Coronary flow velocity reserve and indices describing aortic distensibility in patients after coronary angiography
386
Coronary flow velocity reserve does not correlate with TIMI frame count in patients undergoing non-emergency percutaneous coronary intervention Original Research Article
387
Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease : Results from the pilot phase of the Women’s Ischemi Syndrome Evaluation (WISE) Study
388
Coronary flow, VO2 peak and anaerobic threshold in patients with dilated cardiomyopathy
389
Coronary flow: how far can we go with echocardiography?
390
Coronary Flow: The Holy Grail of Echocardiography?
391
Coronary grafting using a temporary intraluminal shunt instead of heart-lung bypass
392
Coronary Health Improvement Project (CHIP) is associated with improved nutrient intake and decreased depression
393
Coronary heart disease and associated risk factors in Qazvin: a population-based study
394
Coronary heart disease and chlamydia pneumoniae DNA in blood mononuclear cells
395
Coronary heart disease and lipid-modifying treatment in african american patients
396
Coronary heart disease and vitamin E
397
Coronary heart disease deaths and infarctions in people with little or no coronary calcium
398
Coronary heart disease in Chile
399
Coronary heart disease in Indian Asians
400
Coronary heart disease in Indian Asians
401
Coronary Heart Disease in Patients With Diabetes: Part I: Recent Advances in Prevention and Noninvasive Management Review Article
402
Coronary Heart Disease in Patients With Diabetes: Part II: Recent Advances in Coronary Revascularization Review Article
403
Coronary heart disease in people of south-Asian origin
404
Coronary heart disease in seven countries
405
Coronary heart disease in South Asia: Need to redefine risk
406
Coronary heart disease inequalities: deaths and the socio-economic environment in Nottingham, England
407
Coronary heart disease is a multifactorial disease
408
Coronary heart disease mortality among Arab and Jewish residents of Jerusalem
409
Coronary Heart Disease Mortality Among Young Adults in the U.S. From 1980 Through 2002: Concealed Leveling of Mortality Rates Original Research Article
410
Coronary heart disease mortality and sudden death among the 35–44-year age group in Allegheny County, Pennsylvania
411
Coronary heart disease mortality for six ethnic groups in California, 1990–2000
412
Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study
413
Coronary heart disease risk factors and menopause: a study in 1684 French women Original Research Article
414
Coronary heart disease risk factors in urban bus drivers
415
Coronary heart disease risk-factor profile in a lower middles class urban community in Pakistan
416
Coronary heart disease still dropping in UK
417
CORONARY HEART DISEASE TOGETHER WITH DIABETES POSES A SERIOUS HEALTH THREAT
418
Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: Meta-analyses of prospective studies, , ,
419
Coronary heart disease, shared care, and cholesterol
420
Coronary heart disease, stroke, and hypertension in a U.S. National cohort: The NHANES I Epidemiologic Follow-up Study
421
Coronary heart disease, type 2 diabetes mellitus and cardiovascular disease risk factors: a study on a middle-aged and elderly population
422
Coronary heart disease: Intervention for intimate relationship issues Original Research Article
423
Coronary Heart Disease: Pandemic in a True Sense
424
Coronary heart disease: where have we been and where are we going?
425
Coronary heart disease:: At the interface of molecular genetics and preventive medicine
426
Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon
427
Coronary hemodynamics in patients with symptomatic hypertrophic cardiomyopathy
428
Coronary hemodynamics of stent implantation after suboptimal and optimal balloon angioplasty
429
Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up
430
Coronary in-stent restenosis following beta brachytherapy A histopathological examination
431
Coronary in-stent restenosis: Current status and future strategies
432
Coronary Insufficiency After Stentless Aortic Root Replacement: Risk Factors and Solutions
433
Coronary insufficiency in children: Review of literature and report of a rare case with unknown aetiology
434
Coronary intervention at hospitals without on-site cardiac surgery: are we pushing the envelope too far?
435
Coronary Intervention Without a Safety Net
436
Coronary Intervention, Restenosis and Complications
437
Coronary interventional procedures in pediatric heart transplant recipients with cardiac allograft vasculopathy
438
Coronary interventions: clinical outcomes and non-stent techniques
439
Coronary interventions: keeping score
440
Coronary intravascular ultrasound: implications for understanding the development and potential regression of atherosclerosis
441
Coronary involvement in Takayasuʹs arteritis
442
Coronary ischemia and percutaneous intervention
443
Coronary ischemia induced Wolf Parkinson White syndrome
444
Coronary ischemic disease, arterial stiffness, and pulse pressure
445
Coronary Ischemic Events after First Atrial Fibrillation: Risk and Survival
446
Coronary lesions at increased risk
447
Coronary lumen at six-month follow-up of a new radiopaque cordis tantalum stent using quantitative angiography and intracoronary ultrasound
448
Coronary Magnetic Resonance Imaging: Coming of Age
449
Coronary malperfusion due to type a aortic dissection: mechanism and surgical management
450
Coronary microcirculation evaluation with transesophageal echocardiography Doppler in type II diabetics
451
Coronary microcirculation: Physiology and mechanics
452
Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina
453
Coronary microembolization
454
Coronary microembolization
455
Coronary Microembolization: the Role of TNF- α in Contractile Dysfunction
456
Coronary microvascular abnormalities in Chagasʹ disease
457
Coronary microvascular dilation is impaired during cold pressor test in diabetic patients with angiographically normal coronary arteries
458
Coronary Microvascular Dysfunction and Diastolic Load Correlate With Cardiac Troponin T Release Measured by a Highly Sensitive Assay in Patients With Nonischemic Heart Failure
459
Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study
460
Coronary microvascular endothelial cell growth regulates expression of the gene encoding p22-phox
461
Coronary Microvascular Function and Cortical Pain Processing in Patients With Silent Positive Exercise Testing and Normal Coronary Arteries
462
Coronary microvascular function and myocardial metabolism in patients with dilated cardiomyopathy
463
Coronary microvascular function and myocardial metabolism in the pig model of pacing induced progressive LV dysfunction
464
Coronary Microvascular Reactivity After Ischemic Cold Storage and Reperfusion
465
Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia: Results From the National Heart, Lung and Blood Institute WISE (Womenʹs Ischemia Syndrome Evaluation) Study
466
Coronary microvascular response to intracoronary administration of nicorandil
467
Coronary microvascular spasm and angina pectoris
468
Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina
469
Coronary microvascular spasm in patients with vasospastic angina
470
Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor
471
Coronary morphologic findings after stent implantation
472
Coronary MRI: More Pretty Pictures or Present-Day Value?
473
Coronary Multidetector Computed Tomography: A New Standard for Preoperative Risk Assessment?
474
Coronary Myocardial Bridges: Pathophysiology and Clinical Relevance
475
Coronary narrowing secondary to compression by pericardial hydatid cyst
476
Coronary no-flow and ventricular tachycardia associated with habitual marijuana use
477
Coronary No-reflow Phenomenon: A Review of Therapeutic Pharmacological Agents
478
Coronary obstruction by a calcific pericardial ring
479
Coronary operations in octogenarians: can we select the patients?
480
Coronary operations in patients with spinal cord injury
481
Coronary ostial enlargement to prevent stenosis after prosthetic aortic valve replacement
482
Coronary ostial patch angioplasty in children
483
Coronary ostial reconstruction
484
Coronary Ostial Stenosis After Aortic Valve Replacement, Revisited
485
Coronary perforation during unprotected left main angioplasty. Management with conservative approach: a case report
486
Coronary perforation managed with covered stent
487
Coronary perfusate composition influences diastolic properties, myocardial water content, and histologic characteristics of the rat left ventricle
488
Coronary perfusion methods during off-pump coronary artery bypass: results of a randomized clinical trial
489
Coronary perfusion pressure during cardiopulmonary resuscitation
490
Coronary plague instability in severe acute respiratory syndrome
491
Coronary plaque as a replacement for age as a risk factor in global risk assessment
492
Coronary Plaque Burden and Cardiovascular Risk Factors: Single-Point Versus Serial Assessment
493
Coronary plaque burden detected by multislice computed tomography after acute myocardial infarction with near-normal coronary arteries by angiography
494
Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation
495
Coronary plaque composition, macrophage infiltration and tissue factor content in patients with diabetes mellitus
496
Coronary Plaque Composition: Multifactorial Contribution
497
Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease
498
Coronary plaque morphologic characteristics early and late after heart transplantation: In vivo analysis with intravascular ultrasonography,
499
Coronary plaque regression: role of low density lipoprotein-apheresis
500
Coronary Plaque Rupture and Vessel Remodeling
501
Coronary pseudoaneurysm: An uncommon cause of P.U.O. after a common procedure: An interesting case report
502
Coronary Pseudoaneurysm: An Unreported Complication of Castleman’s Disease
503
Coronary pseudoaneurysms are a known complication of the Bentall wrap-inclusion method of composite valve grafting. We describe two cases to illustrate a straightforward technique for repair and prevention of coronary pseudoaneurysm formation.
504
Coronary pseudo-lesions induced in the left anterior descending and right coronary artery by the angioplasty guide-wire
505
Coronary reactivity to nitroglycerin: Intravascular ultrasound evidence for the importance of plaque distribution
506
Coronary Recanalization by Elective Angioplasty Prevents Ventricular Dilation After Anterior Myocardial Infarction
507
Coronary recanalization in anterior myocardial infarction: The open perforator hypothesis
508
Coronary Reimplantation After Neoaortic Reconstruction Can Yield Better Result in Arterial Switch Operation: Comparison With Open Trap Door Technique
509
Coronary Reimplantatıon After Neoaortic Reconstruction in Arterial Switch Operation
510
Coronary Reimplantation During Jatene Procedure
511
Coronary reimplantation in aortic root replacement: a method to avoid tension
512
Coronary remodeling of proximal and distal stenotic atherosclerotic plaques within the same artery by intravascular ultrasound study
513
Coronary reoperation via small laparotomy using right gastroepiploic artery without CPB
514
Coronary reoperations: recurrence of angina and clinical outcome with and without cardiopulmonary bypass
515
Coronary reperfusion: numerators searching for denominators
516
Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents
517
Coronary restenosis: a new strategy for the future?
518
Coronary restenosis: a review of mechanisms and management
519
Coronary Revascularization and Cardiac Catheterization in the United States: Trends in Racial Differences
520
Coronary revascularization and quality of life
521
Coronary Revascularization Before Noncardiac Vascular Surgery: One More Step Forward in Understanding Its Role
522
Coronary Revascularization for Patients With Diabetes: Updated Data Favor Coronary Artery Bypass Grafting
523
Coronary revascularization in older women and men in the United States: trends in ethnic differences
524
Coronary Revascularization in the Community: A Population-Based Study, 1990 to 2004 Original Research Article
525
Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction
526
Coronary revascularization is under-utilized in medicaid patients with acute myocardial infarction
527
Coronary revascularization of the circumflex
528
Coronary Revascularization Strategies in Patients With Diabetes and Multivessel Coronary Artery Disease: Has the Final Chapter Been Written?
529
Coronary Revascularization Strategy and Outcomes According to Blood Pressure (from the International Verapamil SR-Trandolapril Study [INVEST])
530
Coronary Revascularization Surgery After Myocardial Infarction: Impact of Bypass Surgery on Survival After Thrombolysis
531
Coronary revascularization with arterial conduits collateral to the lower limb
532
Coronary revascularization with or without cardiopulmonary bypass in patients with preoperative nondialysis-dependent renal insufficiency
533
Coronary revascularization without cardiopulmonary bypass in high-risk patients: a route to the future
534
Coronary revascularization without cardiopulmonary bypass in patients with pectus excavatum
535
Coronary Revascularization Without Cardiopulmonary Bypass Versus the Conventional Approach in High-Risk Patients
536
Coronary risk assessment in women
537
Coronary risk assessment in women
538
Coronary risk assessment methods and cholesterol lowering
539
Coronary risk assessment methods and cholesterol lowering
540
Coronary risk assessment methods and cholesterol lowering
541
Coronary risk assessment methods and cholesterol lowering
542
Coronary risk assessment methods and cholesterol lowering
543
Coronary risk assessment methods and cholesterol lowering
544
Coronary risk assessment methods and cholesterol lowering
545
Coronary risk factor status after percutaneous transluminal coronary angioplasty
546
Coronary risk factors and coronary atheroma burden at severely narrowing segments
547
Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants
548
Coronary Risk Factors and Myocardial Perfusion in Asymptomatic Adults: The Multi-Ethnic Study of Atherosclerosis (MESA) Original Research Article
549
Coronary risk factors in Indians
550
Coronary risk factors in patients with early-onset coronary disease and normal coronariography
551
Coronary risk factors in people from the Indian subcontinent
552
Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India
553
Coronary risk factors in women six months after coronary artery bypass grafting
554
Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: The muscatine study
555
Coronary risk reduction through intensive community-based lifestyle intervention: the Coronary Health Improvement Project (CHIP) experience
556
Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis: The Heinz Nixdorf Recall Study
557
Coronary rotational ablation for calcific coronary artery stenosis in a young child
558
Coronary ruptured plaque mimicking spontaneous coronary dissection in a young woman
559
Coronary Segmental Responses to Acetylcholine and Bradykinin in Patients With Atherosclerotic Risk Factors
560
Coronary sinus adrenomedullin rises in response to myocardial injury
561
Coronary Sinus and Ascending Aortic Levels of Aldosterone, Angiotensin II, and B-Type Natriuretic Peptide in Patients With Aortic Stenosis and in Patients With Coronary Heart Disease
562
Coronary sinus catheterization via a femoral vein
563
Coronary sinus dilatation is a sign of impaired right ventricular function in patients with heart failure
564
Coronary sinus diverticulum as a cause of resistant posteroseptal pathway ablation
565
Coronary sinus interventions in cardiac surgery, 2nd edition: Edited by Werner Mohl, MD, PhD, Georgetown, Texas, Landes Bioscience, 2000, 224 pp, illustrated, $99.00, ISBN: 1-58706-006-X
566
Coronary Sinus Orifice Atresia With Left Superior Vena Cava in Patients With Univentricular Heart
567
Coronary sinus ostial atresia with persistent left superior vena cava
568
Coronary sinus ostial atresia: A rare associated anomaly that should be remembered in patients undergoing univentricular palliation
569
Coronary sinus pacing mistaken as interventricular septal perforation and subsequent left ventricular pacing by a transvenously introduced pacing electrode
570
Coronary Sinus Reducer Stent for the Treatment of Chronic Refractory Angina Pectoris: A Prospective, Open-Label, Multicenter, Safety Feasibility First-in-Man Study Original Research Article
571
Coronary Sinus Stenting for the Management of Left Ventricular Lead Displacement during Resynchronization Therapy: A Report of Two Cases
572
Coronary sinus thrombosis after cannulation during cardiopulmonary bypass
573
Coronary Slow Flow Phenomenon Clinical Findings and Predictors
574
Coronary slow flow: Benign or ominous?
575
Coronary Slow-Flow Phenomenon or Syndrome Y: A Microvascular Angina Awaiting Recognition
576
Coronary spasm after injection of ondansetron: Case report and review of the literature
577
Coronary spasm and hypersensitivity to amoxicillin: Kounis or not Kounis syndrome?
578
Coronary Stenosis Detection by 16-Slice Computed Tomography in Heart Transplant Patients: Comparison With Conventional Angiography and Impact on Clinical Management Original Research Article
579
Coronary stenosis dilatation induced by L-arginine
580
Coronary stent
581
Coronary stent assessment on multidetector computed tomography: Source and predictors of image distortion
582
Coronary Stent Design and New Clinical Trial Insights
583
Coronary Stent Fracture and In-Stent Restenosis at Coronary Computed Tomography
584
Coronary stent fracture and restenosis in the drug-eluting stent era: Do we have clues of management?
585
Coronary stent fracture in a saphenous vein graft to right coronary artery — Successful treatment by the novel use of the Jomed coronary stent graft: Case report and review of the literature
586
Coronary stent grafts covered by a polytetrafluoroethylene membrane
587
Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution
588
Coronary stent implantation in acute myocardial infarction,
589
Coronary stent implantation in patients older than 75 years of age: Clinical profile and initial and long-term (3 years) outcome
590
Coronary stent implantation is superior to balloon angioplasty for chronic coronary occlusions: Six-year clinical follow-up of the GISSOC trial
591
Coronary stent implantation may seal the inflammatory response in patients with acute coronary syndromes
592
Coronary stent occlusion following strenuous exertion: is the risk actual? Is it preventable?
593
Coronary stent occlusion: Thrombus horribilis
594
Coronary Stent Placement in Patients With Acute Myocardial Infarction: Comparison of Clinical and Angiographic Outcome After Randomization to Antiplatelet or Anticoagulant Therapy
595
Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III Trial
596
Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial
597
Coronary stenting after rotational atherectomy in diffuse lesions of the small coronary artery: comparison with balloon angioplasty prior to stenting
598
Coronary stenting after unsuccessful emergency angioplasty in acute myocardial infarction: Results in a series of consecutive patients
599
Coronary Stenting and Inflammation
600
Coronary Stenting and Inflammation: Implications for Further Surgical and Medical Treatment
601
Coronary stenting and use of abciximab
602
Coronary stenting during acute myocardial infarction. Results from the stent without coumadin French registry
603
Coronary stenting for transplant coronary artery disease
604
Coronary stenting for treatment of ostial stenoses of native coronary arteries or aortocoronary saphenous venous grafts
605
Coronary stenting in cardiac allograft vasculopathy
606
Coronary stenting in diabetic patients: Results from the ROSETTA registry
607
Coronary stenting in patients undergoing percutaneous transluminal coronary angioplasty during acute myocardial infarction
608
Coronary stenting in the setting of spontaneous coronary artery dissection
609
Coronary stenting of bifurcation lesions using “T” or “reverse Y” configuration with Wiktor stent
610
Coronary stenting of unprotected left main stem stenoses in elderly patients unsuitable for coronary surgery
611
Coronary stenting or percutaneous transluminal coronary angioplasty prior to noncardiac surgery increases adverse perioperative cardiac events: the evidence is mounting
612
Coronary stenting or percutaneous transluminal coronary angioplasty prior to noncardiac surgery increases adverse perioperative cardiac events: the evidence is mounting: Reply
613
Coronary stenting versus balloon angioplasty for acute myocardial infarction: A meta-regression analysis of randomized trials
614
Coronary stenting versus balloon angioplasty in small vessels
615
Coronary stenting versus balloon angioplasty in small vessels: A meta-analysis from 11 randomized studies Original Research Article
616
Coronary stenting with novel stainless steel balloon-expandable stent: Determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model
617
Coronary stenting with angioscopic guidance
618
Coronary stenting with AVE microstents in acute myocardial infarction
619
Coronary stents: A health system perspective, ,
620
Coronary stents: A materials perspective
621
Coronary stents: An industry perspective, ,
622
Coronary stents—open choices for closed arteries
623
Coronary subclavian steal: A recurrent case with notes on detecting the threat potential
624
Coronary Superficial and Spotty Calcium Deposits in Culprit Coronary Lesions of Acute Coronary Syndrome as Determined by Optical Coherence Tomography
625
Coronary surgery in patients with peripheral vascular disease: effect of avoiding cardiopulmonary bypass
626
Coronary Surgery in Patients With Preexisting Chronic Atrial Fibrillation: Early and Midterm Clinical Outcome
627
Coronary surgery with intermittent aortic cross-clamping: a word of caution on the incidence of cerebrovascular accidents: letter 2
628
Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response
629
Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosis Original Research Article
630
Coronary thrombosis
631
Coronary thrombosis associated with inherited protein S deficiency: A case report
632
Coronary Thrombosis From Large, Nonprotruding, Superficial Calcified Coronary Plaques
633
Coronary Thrombosis without Dissection following Blunt Trauma
634
Coronary to pulmonary artery collaterals in patients with pulmonary atresia and ventricular septal defect
635
Coronary to pulmonary artery fistula detected by transthoracic echocardiography
636
Coronary tracheal collaterals after heart–lung transplant
637
Coronary vascular dysfunction in premenopausal women with diabetes mellitus
638
Coronary Vascular Morphology in Pressure-overload Left Ventricular Hypertrophy
639
Coronary vascular reactivity is abnormal in patients with Chagasʹ heart disease
640
Coronary Vascular Remodeling in Association With Endothelial Dysfunction
641
Coronary vascular reserve is similarly reduced in hypertensive patients without any other coronary risk factors and in normotensive smokers and hypercholesterolemic patients with angiographically normal coronary arteries
642
Coronary vascular responses to short-term cocaine administration in conscious baboons compared with dogs
643
Coronary Vascular Responsiveness to Adenosine Is Impaired Additively by Blockade of Nitric Oxide Synthesis and Sulfonylure
644
Coronary vasoconstriction after coronary angioplasty is attenuated by endothelin a receptor antagonism
645
Coronary vasoconstriction induced by mental stress (simulated public speaking)
646
Coronary Vasoconstrictive Effects of Neuropeptide Y and Their Modulation by the ATP-Sensitive Potassium Channel in Anesthetized Dogs
647
Coronary vasodilation by noninvasive transcutaneous ultrasound: An in vivo canine study
648
Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction
649
Coronary vasodilator reserve: a clue to the explanation of 201Tl redistribution patterns early after successful primary stenting for acute myocardial infarction
650
Coronary vasodilator responses to bradykinin in euglycemic and diabetic rats
651
Coronary vasodilatory capacity and flow reserve are attenuated in normal myocardium supplied by bypass grafts
652
Coronary vasodilatory capacity and flow reserve in normal myocardium supplied by bypass grafts late after surgery
653
Coronary vasomotility and myocardial blood flow early after heart transplantation
654
Coronary Vasomotion After Percutaneous Transluminal Coronary Angioplasty Depends on the Severity of the Culprit Lesion
655
Coronary vasomotion and exercise‑induced adaptations in coronary artery disease patients: A systematic review and meta‑analysis
656
Coronary vasomotion during dynamic exercise: Influence of intravenous and intracoronary nicardipine
657
Coronary vasomotor function in a normotensive, nondiabetic referral population with normal coronary arteriograms
658
Coronary vasomotor reactivity among normotensive african and white american subjects with chest pain
659
Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: Contrasting myocardial blood flow responses to short- and long-term vitamin C administration
660
Coronary Vasospasm and Coronary Atherosclerosis: Do We Have to Choose?
661
Coronary vasospasm and raspberry ketones weight-loss supplement: Is there a connection?
662
Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil
663
Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease
664
Coronary vasospasm due to hypercholinergic crisis: An example of normal coronary arteriogram and myocardial infarction
665
Coronary vasospasm during an adenosine stress test
666
Coronary vasospasm in a patient suffering from sarin poisoning
667
Coronary Vasospasm Induced During Isoproterenol Head-Up Tilt Test
668
Coronary vasospasm secondary to hypercholinergic crisis: An iatrogenic cause of acute myocardial infarction in myasthenia gravis
669
Coronary vasospasm-induced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease
670
Coronary vein balloon angioplasty forleft ventricular pacemaker lead implantation
671
Coronary venous angioplasty to a ring- like stricture preventing left ventricular lead insertion
672
Coronary venous imaging with electron beam computed tomographic angiography: Three-dimensional mapping and relationship with coronary arteries
673
Coronary ventricular fistula as a complication of PTCA: A case report and literature review
674
Coronary vessel trees from 3D imagery: A topological approach
675
Coronary wallstents show significant late, postprocedural expansion despite implantation with adjunct high-pressure balloon inflations
676
Coronary-artery bypass surgery and the brain: persisting concerns
677
Coronary-Artery Stent
678
Coronary-Cameral Fistula Connecting the Left Anterior Descending Artery and the First Obtuse Marginal Artery to the Left Ventricle: A Rare Finding
679
Coronary-cameral fistula in an asymptomatic adult patient
680
Coronary-coronary bypass using the radial artery
681
Coronary-coronary radial artery graft for single, distal LAD lesion
682
Coronary-pulmonary artery fistula: Heart-on-a-heart appearance
683
Coronary-pulmonary fistula serving as a collateral source to the occluded coronary artery in a patient with myocardial infarction
684
Coronary-pulmonary steal syndrome
685
Coronary-Subclavian Steal Syndrome Following CABG: a Case Report and Literature Review
686
Coronary-subclavian steal syndrome in a hemodialysis patient with ipsilateral subclavian artery occlusion and contralateral vertebral artery stenosis “Case Report”
687
Coronary–Subclavian Steal Syndrome: An usual cause of refractory unstable angina
688
Coronary-to-coronary bypass using a free internal mammary artery: An alternative
689
Coronas and iridescence in mountain wave clouds
690
Coronas of balleans
691
CORONAS-F observations of active phenomena on the sun Original Research Article
692
CORONAS-F satellite: Tasks for study of particle acceleration Original Research Article
693
Coronatine alleviates salinity stress in cotton by improving the antioxidative defense system and radical-scavenging activity
694
Coronatine, a more powerful elicitor for inducing taxane biosynthesis in Taxus media cell cultures than methyl jasmonate
695
Coronavirus (COVID-19) and Possibilities for Criminal Law Reaction in Europe: A Review
696
Coronavirus (COVID-19) Infection in Newborns
697
Coronavirus (SARS-CoV-2) Deactivation via Spike Glycoprotein Shielding by Old Drugs: Molecular Docking Approach
698
Coronavirus and Divine Justice and its Relation to the Issue of Natural and Moral Evil
699
Coronavirus and Emergence of an Extraordinary Political Economy: editorial note
700
Coronavirus Anxiety: The Predictive Role of Perfectionism and Self-compassion
701
Coronavirus as a possible cause of severe acute respiratory syndrome
702
Coronavirus confirmed as cause of SARS
703
Coronavirus COVID-19 and its Effect on Erection and Patients’ Sexual Disorders: A Narrative Review
704
Coronavirus Disease (COVID-19) and Dental Treatment
705
Coronavirus Disease (COVID-19): 10 Questions and Discussion Points for Diabetes and COVID-19
706
Coronavirus Disease 19 with Spontaneous Pneumomediastinum: A Report of Three Cases
707
Coronavirus disease 2019 (COVID-19) and cardiovascular events
708
Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology
709
Coronavirus Disease 2019 (COVID-19) in adolescents: An update on current clinical and diagnostic characteristics
710
Coronavirus Disease 2019 (Covid-19) in Middle East: Data, Facts and Doubts
711
Coronavirus disease 2019 (COVID-19) manifestations during pregnancy in all three trimesters: A case series
712
Coronavirus Disease 2019 (COVID-19) Outbreak in Pediatrics and the Role of Pediatricians: A Systematic Review
713
Coronavirus Disease 2019 (COVID-19): A Systematic Review of Pregnancy and the Possibility of Vertical Transmission
714
Coronavirus Disease 2019 (COVID-19): review study
715
Coronavirus Disease 2019- Challenges Today and Tomorrow in Orthodontic Practice: A Review
716
Coronavirus Disease 2019 in Children with Acute Respiratory Infection: A Study From Southeastern Iran
717
Coronavirus Disease 2019 in Patients with Thalassemia; Emerging Challenges
718
Coronavirus Disease 2019 Occupational Considerations for Surgeons: A Review Article
719
Coronavirus Disease 2019 Vaccine Hesitancy in the Kurdistan Region: A Cross-Sectional National Survey
720
Coronavirus disease 2019: Global Contamination and Global Cleanup
721
Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential
722
Coronavirus Disease in Cardiovascular Patients: Clinical Characteristics and Final Prognosis
723
Coronavirus Disease-19 (COVID-19) Presenting with Severe Acute Pancreatitis: A Case Report from Iran
724
Coronavirus Disease-2019 Infection in Neonates of an Infected Pregnant Mother with Triplets
725
Coronavirus in severe acute respiratory syndrome (SARS)
726
Coronavirus Incidence Rate Estimation from Social Media Data in Iran
727
Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features
728
Coronavirus N Protein N-Terminal Domain (NTD) Specifically Binds the Transcriptional Regulatory Sequence (TRS) and Melts TRS-cTRS RNA Duplexes
729
Coronavirus Pandemic and Worries during Pregnancy; a Letter to Editor
730
Coronavirus phylogeny based on triplets of nucleic acids bases
731
Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses
732
Coronavirus, Its Neurologic Manifestations, and Complications
733
Coronavirus: Bibliometric analysis of scientific publications from 1968 to 2020
734
Coronavirus: Discover the Structure of Global Knowledge, Hidden Patterns & Emerging Events
735
Coronavirus: Nursing Students’ Knowledge and Risk Perception of Clinical Practice during the Pandemic
736
Coronavirus: Where Has All the Health Economics Gone?
737
Coronaviruses and gastrointestinal symptoms: an old liaison for the new SARS-CoV-2
738
Coronaviruses Pathogens in Human in Third Millennium (SARS-CoV, MERS, COVID-19): A Review Article
739
Coronavirus-induced Anxiety among Pregnant Women
740
Coronavirus-nephropathy; renal involvement in COVID-19
741
Coronavirus-Related Opportunities for Promoting Occupational Health and Safety
742
Coroner autopsies originating from complaints to the police in a Nigerian Urban centre
743
Coroner Wakley: two remarkable eyewitness accounts
744
Coroners and public health
745
Coronilla juncea is both a nutritive fodder shrub and useful in the rehabilitation of abandoned Mediterranean marginal farmland
746
Coronin 1B Antagonizes Cortactin and Remodels Arp2/3-Containing Actin Branches in Lamellipodia
747
Coronin 1B Coordinates Arp2/3 Complex and Cofilin Activities at the Leading Edge
748
Coronin-1A Stabilizes F-Actin by Bridging Adjacent Actin Protomers and Stapling Opposite Strands of the Actin Filament
749
Coronoid systems with perfect matchings Original Research Article
750
Corono-radicular biological restoration of maxillary central incisors by direct method
751
Corosolic acid induces apoptosis through mitochondrial pathway and caspases activation in human cervix adenocarcinoma HeLa cells
752
Corosolic acid induces apoptotic cell death in human lung adenocarcinoma A549 cells in vitro
753
COROT: A minisat for pionnier science, asteroseismology and planets finding Original Research Article
754
CoRoT: Harvest of the exoplanet program
755
Co-rotation constructions of residuated semigroups
756
Corotation resonances and planetary formation
757
Co-rotational beam elements with warping effects in instability problems Original Research Article
758
Co-rotational dynamic analysis of flexible beams Original Research Article
759
Co-rotational finite element formulation for thin-walled beams with generic open section Original Research Article
760
Co-rotational flat facet triangular elements for shell instability analyses Original Research Article
761
Co-rotational formulation for geometric nonlinear analysis of doubly symmetric thin-walled beams Original Research Article
762
Corotational formulation for nonlinear dynamics of beams with arbitrary thin-walled open cross-sections
763
Corotational mixed finite element formulation for thin-walled beams with generic cross-section
764
Corotational non-linear analysis of thin plates and shells using a new shell element
765
Corotational nonlinear dynamic analysis of laminated composite shells
766
CORPORA AMYLACEA IN HUMAN CADAVERIC BRAIN AGE RELATED DIFFERENCES
767
CORPORA IN LANGUAGE RESEARCH IN MALAYSIA
768
Corpora Lutea Diameter, Plasma Progesterone Concentration and Follicular Development in PGF2α and CIDR Estrus Synchronized Goats
769
CORPORA USE IN THE TEACHING OF ENGLISH WRITING
770
Corporal punishment and child adjustment
771
Corporal Punishment and its Effects in Pakistan
772
Corporal punishment and physical maltreatment against children: A community study on Chinese parents in Hong Kong
773
Corporal punishment and primary prevention of physical abuse
774
Corporate "central nervous system" software
775
Corporate and Institutional Transparency for Economic Growth in Europe, Oxelheim Lars (Ed.). Elsevier, Amsterdam (2006) 444p, € 76.99, ISBN 0-08-044665-5.
776
Corporate and social performance links in the gaming industry
777
Corporate asset purchases and sales: Theory and evidence
778
Corporate bankruptcies and official bail-outs: A cost–benefit analysis
779
Corporate behavior and competitiveness: impact of environmental regulation on Chinese firms
780
CORPORATE BLOGS AS ACORPORATECOMMUNICATION STRATEGY
781
Corporate board attributes and bankruptcy
782
Corporate boards and regulation: The effect of the Sarbanes–Oxley Act and the exchange listing requirements on firm value
783
Corporate body name changes: Helping the user search efficiently and effectively
784
Corporate bond default risk: A 150-year perspective
785
Corporate bond liquidity and matrix pricing
786
Corporate bond liquidity before and after the onset of the subprime crisis
787
Corporate bond ratings changes and economic instability: Evidence from the Korean financial crisis
788
Corporate Call Policy for Nonconvertible Bonds
789
Corporate capital structure and the characteristics of suppliers and customers
790
Corporate capital structure in turbulent times: a case study of the US airline industry
791
Corporate capture and Coca-Cola
792
Corporate cash flow and stock price exposures to foreign exchange rate risk
793
Corporate cash holdings and CEO compensation incentives
794
Corporate cash holdings: An empirical investigation of UK companies
795
Corporate Champions: doing good more effectively
796
Corporate characteristics, governance attributes and the extent of voluntary disclosure in Bangladesh
797
Corporate citizenship and public relations: The importance and interactivity of social responsibility issues on corporate websites
798
Corporate citizenship and the employee/citizen solider
799
Corporate comets or typical trajectories?: Corporate dynamics in the 1990s
800
Corporate communications managers in large firms: new challenges
801
Corporate Community Involvement. The Definitive Guide to Maximizing Your Business’ Societal Engagement
802
Corporate contracting for health care
803
Corporate control and enterprise structure in the Canadian economy: 1972–1987
804
Corporate control and industry structure in global communications: an introduction
805
Corporate control and real investment in incomplete markets
806
Corporate control and the market for managerial labour: On the decision to go public
807
Corporate control, bank risk taking, and the health of the banking industry
808
Corporate control, expected underpricing, and the choice of issuance mechanism in unseasoned equity markets
809
Corporate cost of occupational accidents: an activity-based analysis
810
Corporate Credibility’s Role in Consumers’ Attitudes and Purchase Intentions When a High versus a Low Credibility Endorser Is Used in the Ad
811
Corporate credit risk modeling and the macroeconomy
812
CORPORATE CRIME ANNOUNCEMENT EFFECTS ON STOCK PERFORMANCE: AN EMPIRICAL STUDY IN MALAYSIA
813
corporate crime in indonesian criminal law system
814
Corporate Cultural Dimensions, Social Responsibility and Financial Performance
815
Corporate Culture and Commitment: Impact on Performance of International New Product Development Programs
816
Corporate culture and the bottom line
817
Corporate culture, absorptive capacity and IT success
818
Corporate culture, related chief executive officer traits, and the development of executive information systems
819
Corporate debt and output pricing in developing countries: Industry-level evidence from Turkey
820
Corporate Default Prediction among Tehran Stock Exchange’s Selected Industries
821
Corporate derivatives use and firm value: Evidence from Turkey
822
Corporate disclosure quality, earnings smoothing, and earningsʹ timeliness
823
Corporate disclosures made by Chinese listed companies
824
Corporate distress and lobbying: Evidence from the Stimulus Act
825
Corporate diversification and asymmetric information: evidence from stock market trading characteristics
826
Corporate diversification and efficiency of manufacturing firms listed in Bursa Malaysia
827
Corporate diversification and performance: evidence on production efficiency
828
Corporate diversification and shareholder value: a survey of recent literature
829
Corporate diversification strategies and capital structure
830
Corporate diversification, information asymmetry and firm performance: Evidence from Tehran Stock Exchange
831
Corporate Diversification, Value Maximization, and Organizational Capabilities
832
Corporate diversification: identifying new businesses systematically in the diversified firm
833
Corporate diversification’s effects on Efficiency and productivity: case study of Manufacturing firms listed in Bursa Malaysia
834
Corporate dynamic transparency: the new ICT-driven ethics?
835
Corporate earnings and the equity premium
836
Corporate elites as informants in qualitative international business research
837
Corporate enterprise: a new reality for hospitality organisations?
838
Corporate entrepreneurs and privatized firms in russia, ukraine, and belarus
839
Corporate entrepreneurship and financial performance: The case of management leveraged buyouts
840
Corporate entrepreneurship antecedents and performance in agricultural advisory services corporations in west of Iran
841
Corporate entrepreneurship in network organizations:: How subsidiary initiative drives internal market efficiency
842
Corporate Entrepreneurship in Training Institutions
843
Corporate entrepreneurship:: antidote or oxymoron?
844
Corporate environme ntal behavior research: informing environme ntal policy
845
Corporate environmental and resource management: In search of a new managerial paradigm
846
Corporate environmental disclosure, financial markets and the media: An international perspective
847
Corporate environmental disclosures: are they useful in determining environmental performance?
848
Corporate environmental disclosures: Competitive disclosure hypothesis using 1991 annual report data
849
Corporate Environmental Innovation (CEI): a government initiative to support corporate sustainability leadership
850
Corporate Environmental Management 2: Culture and Organisations : , Earthscan Publications Ltd (1997) 192 £15.95. Building to Last: The Challenge for Business Leaders, , Earthscan Publications Ltd (1997) 204 £15.95
851
Corporate environmental management and regulation of mining operations in the Cyclades, Greece
852
Corporate environmental market responsiveness: A model of individual and organizational drivers
853
Corporate environmental responsibility in the supply chain
854
Corporate environmental responsiveness in India: lessons from a developing country
855
Corporate environmental strategy: The avalanche of change since Bhopal : B.W. Piasecki (author) John Wiley & Sons, 1995, 180 pp, ISBN 0-471-10627-5, US$24.95
856
Corporate environmentalism: the construct and its measurement
857
CORPORATE EQUAL OPPORTUNITIES (NON-) DISCLOSURE
858
Corporate ergonomics programme at automobiles Peugeot-Sochaux
859
Corporate ergonomics programme at BCM Airdrie
860
Corporate ergonomics programme at Ford Motor Company
861
Corporate ergonomics programme at Scottish & Newcastle
862
Corporate ergonomics programme at Volvo Car Corporation
863
Corporate Excellence in the Year 2000 : L K T , Century (1996), 350 pp., £18.99
864
Corporate Farm Performance in Russia, 1991–1995: An Efficiency Analysis
865
Corporate finance and state enterprise reform in China
866
Corporate finance—Theory and practice
867
Corporate Financial Accounting and Reporting: by Tim Sutton, Financial Times/Prentice Hall, Harlow, Essex, England, 2000, xiii+754 pp
868
Corporate financial decision-makers’ perceptions of workplace safety
869
Corporate financial disclosure in emerging markets: Does economic development matter?
870
CORPORATE FINANCIAL MANAGEMENT: TIME TO CHANGE THE “COST OF CAPITAL” PARADIGM?
871
Corporate Financial Reporting. Theory and Practice: Andrew Higson (Ed.); Sage, 2003, 228 pages, ISBN 0-7619-7141-6 (£24.99)
872
Corporate Financial Reporting: A Global Perspective: by Hervé Stolowy and Michel J. Lebas, Thomson, London, UK, 2002, xxvi+636 pp. ISBN: 1-861-52753-5, £31.99
873
Corporate Financial Reporting: By Bhabatosh Banerjee and Arun Kumar Basu (Eds.), University of Calcutta, Calcutta, 2001, vi+275 pages
874
Corporate Financial Strategies for Global Competitiveness
875
Corporate Financing and Goverance in Japan: The Road to the Future: by Takeo Hoshi and Anil Kashyap, MIT Press, 2002.
876
Corporate financing decisions when investors take the path of least resistance
877
Corporate financing decisions, managerial market timing, and real investment
878
Corporate firms in the 21st century: A note.
879
Corporate focus and stock returns,
880
Corporate focus and value creation evidence from spinoffs
881
Corporate focus versus diversification: the role of growth opportunities and cashflow
882
Corporate fraud, systematic risk, and shareholder enrichment
883
Corporate futures: social responsibility in the tourism industry: Angela Kalisch; Tourism Concern, London, 2002, 47pp, price £15 (£10 for members), ISBN 0-9528567-7-8
884
Corporate goodness and shareholder wealth
885
CORPORATE GOVERNANCE AND ACCOUNTING MODELS OF THE REPORTING ENTITY,
886
Corporate governance and accounting systems: a critical perspective
887
Corporate Governance and Audit Fees: Evidence from a Developing Country
888
Corporate Governance and Audit Opinion Shopping: Evidence from Iran
889
Corporate governance and audit report lag in Malaysia
890
Corporate governance and bank performance: A joint analysis of the static, selection, and dynamic effects of domestic, foreign, and state ownership
891
Corporate governance and board effectiveness
892
Corporate Governance and Corporate Social Responsibility: The Case of Small, Medium, and Large Firms
893
Corporate Governance and Credit Risk in the Iranian Banking Industry
894
Corporate governance and dividend pay-out policy in Germany
895
Corporate governance and dividend policy in emerging markets
896
Corporate governance and dividend policy: A comparison of Chinese firms listed in Hong Kong and in the Mainland
897
Corporate governance and earnings management in the Chinese listed companies: A tunneling perspective
898
Corporate Governance and Employee Ownership in an Economic Crisis: Enterprise Strategies in the Former USSR
899
Corporate governance and executive compensation
900
Corporate governance and firm cash holdings in the US
901
Corporate governance and firm performance: Evidence from Japanese manufacturing industries after the lost decade
902
Corporate governance and firm profitability: evidence from Korea before the economic crisis
903
Corporate governance and firm valuation
904
Corporate governance and firm value: evidence from the Korean financial crisis
905
Corporate governance and firm value\In Japan: Evidence from 1985 to 199
906
Corporate governance and globalization. Long range planning issues: Stephen S. Cohen & Gavin Boyd (Eds); Edward Elgar Publishing, Cheltenham, UK, 2000, pp. 373
907
Corporate governance and information asymmetry
908
Corporate governance and innovation: The UK compared with the US and ‘insider’ economies
909
CORPORATE GOVERNANCE AND INSTITUTIONAL INVESTORS: EVIDENCE FROM MALAYSIA
910
Corporate governance and intellectual capital
911
Corporate Governance and Investment Decisions in Deposit Money Banks in Nigeria
912
Corporate governance and investment in Central and Eastern Europe
913
Corporate governance and investment in East Asian firms—empirical analysis of family-controlled firms
914
Corporate Governance and Iranian Banking Economic Value Added
915
Corporate Governance and Liquidity Creation: Evidence from Iranian Banks
916
Corporate Governance and Liquidity Management: Evidence from Nigerian Deposit Money Banks
917
Corporate governance and lobbying strategies
918
Corporate governance and manager turnover: An unusual social experiment
919
Corporate governance and market valuation in China
920
Corporate governance and market valuation of capital and R&D investments
921
Corporate governance and mass privatisation: A theoretical investigation of transformations in legal and economic relationships
922
Corporate governance and merger performance: Learning from the Australian experience
923
Corporate governance and ownership structure of target companies and the outcome of takeovers
924
Corporate governance and pay-for-performance: The impact of earnings management
925
Corporate governance and performance of small high-tech firms in Sweden
926
Corporate governance and profit manipulation: a French field study
927
CORPORATE GOVERNANCE an‎d PUBLIC RELATIONS: A QUALITATIVE RESEARCH WITH PUBLIC RELATIONS EXPERTS
928
Corporate Governance and R D Reporting in Malaysian MESDAQ Market
929
Corporate governance and recent consolidation in the banking industry
930
CORPORATE GOVERNANCE AND ROLE OF CEO IN ENGINEERING COMPANIES
931
Corporate governance and shareholder initiatives: Empirical evidence
932
Corporate governance and shareholder patience
933
Corporate governance and state-owned shares in China listed companies
934
Corporate governance and the quality of financial analysts’ information
935
Corporate governance and the spinoff decision
936
Corporate governance and the value of cash holdings
937
Corporate governance and voluntary disclosure
938
Corporate Governance and Voluntary Disclosure Practices: Evidence from a Two Tier Board Systems in Indonesia
939
Corporate governance assessment in company board structure
940
Corporate governance attributes, firm characteristics and the level of corporate disclosure: Evidence from the Indian listed firms
941
Corporate Governance Characteristics and Company Performance
942
Corporate Governance Characteristics and Discretionary Accruals Among Non-Financial Firms Listed in Nairobi Securities Exchange
943
Corporate governance digest
944
Corporate governance effectiveness during institutional transitio
945
Corporate governance in China: An overview
946
Corporate governance in china: Explosive growth and new patterns of ownership
947
Corporate Governance in Insurance Sector and The Impact of Corporate Governance Committee
948
Corporate Governance in Russia:: towards a European, US, or Russian Model?
949
Corporate governance in South Korea: the chaebol experience
950
Corporate governance in the Asian countries
951
Corporate governance in the Asian financial crisis
952
CORPORATE GOVERNANCE IN THE CONTEXT OF CORPORATE SUSTAINABILITY: THE BIRTH, THE DEVELOPMENT an‎d THE EVALUATION OF THE CONCEPT
953
Corporate governance in the deregulated telecommunications industry: lessons from the airline industry
954
Corporate Governance in the Former Soviet Union
955
Corporate Governance in the Former Soviet Union: An Overview
956
Corporate Governance In Turkey: An Overview
957
Corporate governance indices and firmsʹ market values: Time series evidence from Russia
958
Corporate governance issues and director compensation structure in Spanish companies
959
Corporate Governance Mechanisms and Financial Performance: Evidence from the Listed Bank in Bangladesh
960
Corporate governance of Japanese banks
961
Corporate governance over the business cycle
962
Corporate Governance Perspectives for Zimbabwean SMEs
963
Corporate governance post-Enron: Effective reforms, or closing the stable door?
964
Corporate Governance Practices and Environmental Reporting of Companies in Malaysia: Finding Possibilities of Double Thumbs Up
965
Corporate Governance Practices in Bangladesh: A Comparative Analysis between Conventional Banks and Islamic Banks
966
Corporate governance practices, CEO characteristics and firm performance
967
Corporate governance proposals and shareholder activism: the role of institutional investors
968
Corporate governance provisions and firm ownership: Firm-level evidence from Eastern Europe
969
Corporate Governance Quality :A Literature Review
970
Corporate Governance Structure, Legal Environment, and Valuation
971
Corporate governance when founders are directors
972
Corporate Governance with the Institutional Theory Approach on Regional Development Banks in Indonesia
973
Corporate Governance, Accountability, and Pressures to Perform: An International Study: by Istemi S. Demirag, JAI Press, Stamford, CT, 1998, xv+395 pp.
974
Corporate governance, bank specific characteristics, banking industry characteristics, and Intellectual Capital (IC) performance of banks in Arab Gulf Cooperation Council (GCC) countries
975
Corporate governance, chief executive officer compensation, and firm performance
976
Corporate governance, competition policy and industrial policy
977
Corporate governance, corporate social responsibility and corporate risk: Evidence on Indonesia
978
Corporate governance, dividend payout policy, and the interrelation between dividends, R&D, and capital investment
979
Corporate Governance, Executive Directors and Level of Voluntary Disclosure: The Case of Public Listed Companies in Thailand
980
Corporate governance, investor protection, and performance in emerging markets
981
Corporate governance, ownership dispersion and efficiency: Empirical evidence from Austrian cooperative banking
982
Corporate governance, Sarbanes-Oxley, and small-cap firm performance
983
Corporate governance, shareholder rights and firm diversification: An empirical analysis
984
Corporate governance, strategic philanthropy, and public policy
985
Corporate governance, top executive compensation and firm performance\In Japan
986
Corporate governance, tourism growth and firm performance: Evidence from publicly listed tourism firms in five Middle Eastern countries
987
Corporate governance: Accountability, enterprise and international comparisons, 2005
988
Corporate Governance: Board Structure, Information Technology and CSR Reporting
989
CORPORATE GOVERNANCE: CAN CREDITORS FIT IN WITH COMPANIES’ BOARD OF DIRECTORS?
990
Corporate governance: Kenneth A. Kim, John R. Nofsinger; Pearson Education Inc., 94 pages, ISBN 0131423878, £19.99
991
CORPORATE GOVERNANCE: NOMINEE DIRECTOR THE GATEKEEPER
992
CORPORATE GOVERNANCE: OVERVIEW AND RESEARCH AGENDA
993
Corporate Governance: SMEs Experience in Metro Cebu, Philippines
994
Corporate Governance: Theory and Some Insights into the Malaysian Practices
995
Corporate governance\In New Zealand: The effect of the 1993 Companies Act on the relation between board composition and firm performance
996
Corporate government digest
997
Corporate groups, dual-class shares and the value of voting rights
998
Corporate Harm Minimisation: Promises and Perils; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, 2019”
999
Corporate heritage identity management and the multi-modal implementation of a corporate heritage identity
1000
Corporate identity: The role of mission statements